The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sargsian A.R.

Pirogov Russian National Research Medical University

Melkonyan N.A.

Pirogov Russian National Research Medical University

Badalova V.A.

Pirogov Russian National Research Medical University

Gurtskaya E.S.

Pirogov Russian National Research Medical University

Dubrovskaya E.V.

Pirogov Russian National Research Medical University

Ter-Nikogosyan G.A.

Pirogov Russian National Research Medical University

Zograbyan G.G.

Pirogov Russian National Research Medical University

Zharova M.E.

Pirogov Russian National Research Medical University

Ivanikov I.O.

Pirogov Russian National Research Medical University;
Central Clinical Hospital with Polyclinic of Administrative Directorate of the President of the Russian Federation

Nikonov E.L.

Pirogov Russian National Research Medical University

Neuroendocrine tumor of the pancreas with liver metastases. Case report

Authors:

Sargsian A.R., Melkonyan N.A., Badalova V.A., Gurtskaya E.S., Dubrovskaya E.V., Ter-Nikogosyan G.A., Zograbyan G.G., Zharova M.E., Ivanikov I.O., Nikonov E.L.

More about the authors

Read: 1582 times


To cite this article:

Sargsian AR, Melkonyan NA, Badalova VA, et al. . Neuroendocrine tumor of the pancreas with liver metastases. Case report. Russian Journal of Evidence-Based Gastroenterology. 2025;14(2):106‑114. (In Russ.)
https://doi.org/10.17116/dokgastro202514021106

Recommended articles:

References:

  1. Sultana Q, Kar J, Verma A, Sanghvi S, Kaka N, Patel N, Sethi Y, Chopra H, Kamal MA, Greig NH. A comprehensive review on neuroendocrine neoplasms: Presentation, pathophysiology and management. Journal of Clinical Medicine. 2023;12(15):5138. https://doi.org/10.3390/jcm12155138
  2. Wu P, He D, Chang H, Zhang X. Epidemiologic trends of and factors associated with overall survival in patients with neuroendocrine tumors over the last two decades in the USA. Endocrine Connections. 2023;12(12):e230331. https://doi.org/10.1530/EC-23-0331
  3. Patel N, Barbieri A, Gibson J. Neuroendocrine tumors of the gastrointestinal tract and pancreas. Surgical Pathology Clinics. 2019;12(4):1021-1044. https://doi.org/10.1016/j.path.2019.08.007
  4. Sonbol MB, Mazza GL, Mi L, Oliver T, Starr J, Gudmundsdottir H, Cleary SP, Hobday T, Halfdanarson TR. Survival and incidence patterns of pancreatic neuroendocrine tumors over the last 2 decades: A SEER database analysis. The Oncologist. 2022;27(7):573-578.  https://doi.org/10.1093/oncolo/oyac049
  5. Klinicheskie rekomendacii. Nejroe`ndokrinny`e opuxoli. Odobreno Nauchno-prakticheskim Sovetom Ministerstva zdravooxraneniya Rossijskoj Federacii. 2020. Accessed February 19, 2025. (In Russ.). https://cr.minzdrav.gov.ru/schema/610_1
  6. Mamedov IYa, Feydorov IYu, Bikeikina TM. Prevalence of neuroendocrine tumors of the gastrointestinal tract. E`ndokrinnaya xirurgiya. 2023;17(4):60. (In Russ.). https://doi.org/10.14341/serg12883
  7. Mamedov IYa, Feydorov IYu. Epidemiology of neuroendocrine tumors on the example of the registry of the Moscow Clinical Research Center named after A.S. Loginov. E`ndokrinnaya xirurgiya. 2023;17(4):56. (In Russ.). https://doi.org/10.14341/serg12879
  8. Kidd M, Modlin IM, Bodei L, Drozdov I. Decoding the molecular and mutational ambiguities of gastroenteropancreatic neuroendocrine neoplasm pathobiology. Cellular and Molecular Gastroenterology and Hepatology. 2015;1(2):131-153.  https://doi.org/10.1016/j.jcmgh.2014.12.008
  9. Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, Ezzat S, de Herder WW, Klimstra DS, Papotti M, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocrine Pathology. 2022;33:115-154.  https://doi.org/10.1007/s12022-022-09708-2
  10. Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, Chan J, Kulke MH, Benson AB, Blaszkowsky LS, Eads J, Engstrom PF, Fanta P, Giordano T, He J, Heslin MJ, Kalemkerian GP, Kandeel F, Khan SA, Kidwai WZ, Kunz PL, Kuvshinoff BW, Lieu C, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Sussman CA, Trikalinos NA, Uboha NA, Whisenant J, Wong T, Yao JC, Burns JL, Ogba N, Zuccarino-Catania G. NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2. Journal of the National Comprehensive Cancer Network. 2018;16(6):693-702.  https://doi.org/10.6004/jnccn.2018.0056
  11. Perren A, Couvelard A, Scoazec JY, Costa F, Borbath I, Delle Fave G, Gorbounova V, Gross D, Grossma A, Jense RT, Kulke M, Oeberg K, Rindi G, Sorbye H, Welin S; Antibes Consensus Conference participants. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Pathology: diagnosis and prognostic stratification. Neuroendocrinology. 2017;105(3):196-200.  https://doi.org/10.1159/000457956
  12. Öberg K, Califano A, Strosberg JR, Ma S, Pape U, Bodei L, Kaltsas G, Toumpanakis C, Goldenring JR, Frilling A, Paulson S. A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood. Annals of Oncology. 2020;31(2):202-212.  https://doi.org/10.1016/j.annonc.2019.11.003
  13. Sundin A, Arnold R, Baudin E, Cwikla JB, Eriksson B, Fanti S, Fazio N, Giammarile F, Hicks RJ, Kjaer A, Krenning E, Kwekkeboom D, Lombard-Bohas C, O’Connor JM, O’Toole D, Rockall A, Wiedenmann B, Valle JW, Vullierme MP; Antibes Consensus Conference participants. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Radiological, nuclear medicine and hybrid imaging. Neuroendocrinology. 2017;105:212-244.  https://doi.org/10.1159/000471879
  14. Turaga KK, Kvols LK. Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors. CA: A Cancer Journal for Clinicians. 2011;61:113-132.  https://doi.org/10.3322/caac.20097
  15. Al-Nahhas A. Nuclear medicine imaging of neuroendocrine tumours. Clinical Medicine. 2012;12:377-380.  https://doi.org/10.7861/clinmedicine.12-4-377
  16. Orel NF, Artamonova EV, Gorbunova VA, Delektorskaya VV, Emel’yanova GS, Lyubimova NV, Markovich AA, Orlova KV, Orlova RV, Trifanov VS. Practical recommendations for drug treatment of neuroendocrine neoplasms of the gastrointestinal tract, pancreas, and other localizations. Zlokachestvennye opukholi. 2021;11(3):499-512. (In Russ.). https://doi.org/10.18027/2224-5057-2021-11-3s2-30
  17. Zyryanov SK, Zatolochina KE. Perspective for use of radionuclide drugs in the treatment of malignant tumors in Russia. Kachestvennaya klinicheskaya praktika. 2018;2:51-57. (In Russ.). https://doi.org/10.24411/2588-0519-2018-10044
  18. Öberg K. Circulating biomarkers in gastroenteropancreatic neuroendocrine tumors. Endocrine-Related Cancer. 2011;18:17-25.  https://doi.org/10.1530/ERC-10-0280

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.